Search

Your search keyword '"Cervarix (Vaccine)"' showing total 244 results
Start Over Descriptor "Cervarix (Vaccine)"
244 results on '"Cervarix (Vaccine)"'

1. Human papillomavirus vaccines: WHO position paper (2022 update)/ Vaccins contre les papillomavirus humains: note de synthese de l'OMS (mise a jour de 2022)

Subjects
Vaccination, Medical policy, Papillomavirus infections, Vaccines, Government, Health, World Health Organization, Cervarix (Vaccine)
Abstract

Introduction In accordance with its mandate to provide normative guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers (1) on vaccines and [...]

Published
2022

3. Supply Of Human Papillomavirus Vaccine- Cervarix Vaccine

Subjects
Papillomaviruses, Papillomavirus infections, Vaccines, Business, international, Cervarix (Vaccine)
Abstract

Tenders are invited for Supply of Human Papillomavirus Vaccine- Cervarix Vaccine. Tender Category : Goods OpeningDate : Jul 17 2023 10:30AM Major organization : South Western Railway Address : Swr-central-hosp-stores/south [...]

Published
2023

4. Human papillomavirus vaccines: WHO position paper, May 2017/ Vaccins contre les papillomavirus humains: note de synthese de l'OMS, mai 2017

Subjects
Vaccines, Papillomavirus infections -- Development and progression, Health policy, Government, Health, World Health Organization, Cervarix (Vaccine)
Abstract

Introduction In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and vaccine combinations [...]

Published
2017

5. Study Findings on Human Papillomavirus 16 Described by Researchers at Ragon Institute [Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination]

Subjects
Merck & Company Inc., Vaccination -- Analysis, Medical research -- Analysis, Medicine, Experimental -- Analysis, Papillomaviruses -- Analysis, Cervical cancer -- Analysis, Pharmaceutical industry -- Analysis, Health, Cervarix (Vaccine)
Abstract

2023 APR 5 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators discuss new findings in human papillomavirus 16. According to news reporting from the Ragon [...]

Published
2023

6. HPV vax unmasks cervical lesions from non-vax strains

Author

Otto, M. Alexander

Subjects
Merck & Company Inc., Vaccination, Papillomavirus infections, Vaccines, Pharmaceutical industry, Health, Health care industry, Cervarix (Vaccine)
Abstract

Vaccines against human papillomavirus have been hailed as a success: They have been shown to decrease the incidence of cervical lesions associated with the HPV types that are in the [...]

Published
2022

7. GSK's HPV vaccine Cervarix approved in China for girls aged 9 to 14

Subjects
Cancer -- Prevention, Papillomavirus infections, Cervical cancer, Vaccines, General interest, News, opinion and commentary, Cervarix (Vaccine)
Abstract

London: GSK PLC has issued the following press release: GSK PLC on Friday said China's National Medical Products Administration has approved the use of its HPV vaccine Cervarix for girls [...]

Published
2022

8. Global Advisory Committee on Vaccine Safety, 11-12 December 2013/Comite consultatif mondial de la Securite vaccinale, 11-12 decembre 2013

Subjects
Australia. Therapeutic Goods Administration -- Safety and security measures, Vaccination, Influenza vaccines, Papillomavirus infections, Influenza, Government, Health, Cervarix (Vaccine), Rota Teq (Vaccine), Rotarix (Vaccine)
Abstract

The Global Advisory Committee on Vaccine Safety (GACVS), an expert clinical and scientific advisory body, was established by WHO to provide independent, scientifically rigorous advice on vaccine safety issues of [...]

Published
2014

9. HPV Vaccination When Young Cuts Cervical Cancer Risk by 87%

Subjects
Oncology, Experimental, Vaccination, Cancer -- Prevention -- Research, Cervical cancer -- Risk factors, Health, Cervarix (Vaccine)
Abstract

THURSDAY, Nov. 4, 2021 (HealthDay News) -- The sooner girls are vaccinated against human papillomavirus (HPV), the lower their future risk of cervical cancer, a new study finds. Compared to [...]

Published
2021

10. LATEST COMPANY NEWS

Subjects
United States. Food and Drug Administration, United States. Supreme Court, Pfizer Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, Eisai Company Ltd., Antidepressants, Papillomavirus infections, Vincristine, Hallucinogenic drugs, Vaccines, Business, international, European Union. European Commission, Cervarix (Vaccine), Polivy (Medication), Advair Diskus (Medication)
Abstract

London World - Europe's first psychedelic drugs research lab is coming to London - 29/5/2022 Europe's first commercial facility for clinical trials of psychedelic drugs is set to open in [...]

Published
2022

11. Cervarix Delivery

Subjects
Business, international, Cervarix (Vaccine)
Abstract

Contract awarded for Cervarix delivery Contractor name : GSK SERVICES SP. Z O. O Contractor address : Street: Grunwaldzka 189 7.3.4) City / town: Poznan 7.3.5) Postal code: 60-322 7.3.6.) [...]

Published
2021

12. Human Papillomavirus (HPV) Vaccines Disease Report 2021: Guidelines, Pipeline, Regulatory Events, Clinical Trials, Marketed Vaccines

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Cervarix (Vaccine)
Abstract

Dublin: Research and Markets has issued the following news release: The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Since the launch of the first [...]

Published
2021

13. Human Papillomavirus (HPV) Vaccines Disease Analysis Report 2021

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Cervarix (Vaccine)
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Since the launch of the first [...]

Published
2021

14. Human Papillomavirus (HPV) Vaccines Disease Market Analysis Report 2021-2023

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Cervarix (Vaccine)
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Since the launch of the first [...]

Published
2021

15. Human Papillomavirus (HPV) Vaccines Disease Report 2021: Guidelines, Pipeline, Regulatory Events, Clinical Trials, Marketed Vaccines

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, international, Law, Cervarix (Vaccine)
Abstract

(GlobeNewswire) - The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Since the launch of the first HPV vaccine in 2006, the market has seen [...]

Published
2021

16. Human Papillomavirus (HPV) Vaccines Disease Report 2021: Guidelines, Pipeline, Regulatory Events, Clinical Trials, Marketed Vaccines

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business, Cervarix (Vaccine)
Abstract

Dublin, July 08, Jul 08, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Since the launch of the [...]

Published
2021

17. Human Papillomavirus (HPV) Vaccines Disease Market Analysis Report 2021-2023

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary, Cervarix (Vaccine)
Abstract

DUBLIN, July 8, 2021 /PRNewswire/ -- The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added toResearchAndMarkets.com's offering. Since the launch of the first HPV vaccine in 2006, the [...]

Published
2021

18. Human Papillomavirus (HPV) Vaccines Disease Analysis Report 2021 - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Cervarix (Vaccine)
Abstract

DUBLIN -- The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Since the launch of the first HPV vaccine in 2006, the market has seen [...]

Published
2021

19. Human Papillomavirus (HPV) Vaccines Disease Analysis Report 2021

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Cervarix (Vaccine)
Abstract

M2 PRESSWIRE-July 7, 2021-: Human Papillomavirus (HPV) Vaccines Disease Analysis Report 2021 (C)1994-2021 M2 COMMUNICATIONS RDATE:07072021 The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2021

20. GlaxoSmithKline (LSE: GSK)

Subjects
GlaxoSmithKline PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Influenza vaccines, Rilpivirine, Dolutegravir, Health care industry -- Forecasts and trends, Pharmacy, Vaccines, Influenza, Drugstores, Market trend/market analysis, Health care industry, Business, international, Advair Diskus (Medication), Avodart (Medication), Benlysta (Medication), Boostrix (Vaccine), Breo Ellipta (Medication), Cervarix (Vaccine), Cialis (Medication), Flonase (Medication), Infanrix (Medication), Juluca (Medication), Menveo (Vaccine), Nucala (Medication), Panadol (Medication), Pediarix (Vaccine), Seretide (Medication), Synflorix (Vaccine), Tanzeum (Medication), Tivicay (Medication), Trelegy Ellipta (Medication)
Abstract

About Us We're a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. GlaxoSmithKline plc [...]

Published
2019

21. GlaxoSmithKline (LSE: GSK)

Subjects
GlaxoSmithKline PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Influenza vaccines, Rilpivirine, Dolutegravir, Health care industry -- Forecasts and trends, Pharmacy, Vaccines, Influenza, Drugstores, Market trend/market analysis, Health care industry, Business, international, Advair Diskus (Medication), Avodart (Medication), Benlysta (Medication), Boostrix (Vaccine), Breo Ellipta (Medication), Cervarix (Vaccine), Cialis (Medication), Flonase (Medication), Infanrix (Medication), Juluca (Medication), Menveo (Vaccine), Nucala (Medication), Panadol (Medication), Pediarix (Vaccine), Seretide (Medication), Synflorix (Vaccine), Tanzeum (Medication), Tivicay (Medication), Trelegy Ellipta (Medication)
Abstract

About Us We're a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. GlaxoSmithKline plc [...]

Published
2019

22. GlaxoSmithKline (LSE: GSK)

Subjects
GlaxoSmithKline PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Influenza vaccines, Rilpivirine, Dolutegravir, Health care industry -- Forecasts and trends, Pharmacy, Vaccines, Influenza, Drugstores, Market trend/market analysis, Health care industry, Business, international, Advair Diskus (Medication), Avodart (Medication), Benlysta (Medication), Boostrix (Vaccine), Breo Ellipta (Medication), Cervarix (Vaccine), Cialis (Medication), Flonase (Medication), Infanrix (Medication), Juluca (Medication), Menveo (Vaccine), Nucala (Medication), Panadol (Medication), Pediarix (Vaccine), Seretide (Medication), Synflorix (Vaccine), Tanzeum (Medication), Tivicay (Medication), Trelegy Ellipta (Medication)
Abstract

About Us We're a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. GlaxoSmithKline plc [...]

Published
2019

23. GlaxoSmithKline (LSE: GSK)

Subjects
Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Influenza vaccines, Rilpivirine, Dolutegravir, Health care industry -- Forecasts and trends, Pharmacy, Vaccines, Influenza, Drugstores, Market trend/market analysis, Health care industry, Business, international, Advair Diskus (Medication), Avodart (Medication), Benlysta (Medication), Boostrix (Vaccine), Breo Ellipta (Medication), Cervarix (Vaccine), Cialis (Medication), Flonase (Medication), Infanrix (Medication), Juluca (Medication), Menveo (Vaccine), Nucala (Medication), Panadol (Medication), Pediarix (Vaccine), Seretide (Medication), Synflorix (Vaccine), Tanzeum (Medication), Tivicay (Medication), Trelegy Ellipta (Medication)
Abstract

About Us We're a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. GlaxoSmithKline pic [...]

Published
2019

24. GlaxoSmithKline (LSE: GSK)

Subjects
GlaxoSmithKline PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Influenza vaccines, Rilpivirine, Dolutegravir, Health care industry -- Forecasts and trends, Pharmacy, Vaccines, Influenza, Drugstores, Market trend/market analysis, Health care industry, Business, international, Advair Diskus (Medication), Avodart (Medication), Benlysta (Medication), Boostrix (Vaccine), Breo Ellipta (Medication), Cervarix (Vaccine), Cialis (Medication), Flonase (Medication), Infanrix (Medication), Juluca (Medication), Menveo (Vaccine), Nucala (Medication), Panadol (Medication), Pediarix (Vaccine), Seretide (Medication), Synflorix (Vaccine), Tanzeum (Medication), Tivicay (Medication), Trelegy Ellipta (Medication)
Abstract

About Us We're a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. GlaxoSmithKline plc [...]

Published
2019

25. GlaxoSmithKline (LSE: GSK)

Subjects
GlaxoSmithKline PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Influenza vaccines, Rilpivirine, Dolutegravir, Health care industry -- Forecasts and trends, Pharmacy, Vaccines, Influenza, Drugstores, Market trend/market analysis, Health care industry, Business, international, Advair Diskus (Medication), Avodart (Medication), Benlysta (Medication), Boostrix (Vaccine), Breo Ellipta (Medication), Cervarix (Vaccine), Cialis (Medication), Flonase (Medication), Infanrix (Medication), Juluca (Medication), Menveo (Vaccine), Nucala (Medication), Panadol (Medication), Pediarix (Vaccine), Seretide (Medication), Synflorix (Vaccine), Tanzeum (Medication), Tivicay (Medication), Trelegy Ellipta (Medication)
Abstract

About Us We're a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. GlaxoSmithKline plc [...]

Published
2019

26. GlaxoSmithKline PLC Vaccines Investor Event - Final

Subjects
GlaxoSmithKline PLC, Vaccines, Pharmaceutical industry, Production management, Business, Cervarix (Vaccine)
Abstract

Presentation SARAH ELTON-FARR, HEAD OF IR, GLAXOSMITHKLINE PLC: Everyone can take their seats. Roger and the Vaccines team are ready to come and talk to you. We're going live on [...]

Published
2019

27. Disease Analysis: Human Papillomavirus (HPV) Vaccines

Subjects
Merck & Company Inc. -- Forecasts and trends, Antigens -- Forecasts and trends, Vaccines -- Forecasts and trends, Papillomavirus -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccination -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business, Cervarix (Vaccine)
Abstract

Dublin, July 28, Jul 28, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Latest Key Takeaways: -- Worldwide [...]

Published
2020

28. Worldwide Human Papillomavirus (HPV) Vaccines Overview 2020 - Pipeline & Marketed Vaccines, Regulatory Events, Clinical Trial Landscape, Future Trends, KOL Insights, Unmet Needs, Sales (2015-2024)

Subjects
Merck & Company Inc. -- Forecasts and trends, Antigens -- Forecasts and trends, Papillomavirus -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Cervarix (Vaccine)
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. Worldwide vaccination programs for human papillomavirus [...]

Published
2020

29. Disease Analysis: Human Papillomavirus (HPV) Vaccines

Subjects
Merck & Company Inc. -- Forecasts and trends, Antigens, Vaccines, Papillomavirus, Papillomavirus infections, Vaccination, Pharmaceutical industry -- Forecasts and trends, Diseases, Market trend/market analysis, General interest, News, opinion and commentary, Cervarix (Vaccine)
Abstract

NEW YORK: Reportlinker has issued the following press release: Latest key takeaways Worldwide vaccination programs for human papillomavirus (HPV) have evolved substantially over the last decade. There are currently three [...]

Published
2020

30. Disease Analysis: Human Papillomavirus (HPV) Vaccines

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination, Papillomaviruses, Papillomavirus infections, Antigens, Vaccines, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary, Cervarix (Vaccine)
Abstract

NEW YORK, Feb. 7, 2020 /PRNewswire/ -- Latest key takeaways Worldwide vaccination programs for human papillomavirus (HPV) have evolved substantially over the last decade. There are currently three approved vaccines [...]

Published
2020

31. Human Papillomavirus HPV Vaccines Disease Analysis Report 2021 - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Forecasts and trends, Vaccination -- Forecasts and trends, Papillomaviruses -- Forecasts and trends, Papillomavirus infections -- Forecasts and trends, Vaccines -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Pharmaceuticals and cosmetics industries, Health, Cervarix (Vaccine)
Abstract

2021 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- The 'Disease Analysis: Human Papillomavirus (HPV) Vaccines' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2021

32. The human papillomavirus (HPV): lost in space

Author

Rochon, Donna

Subjects
Cervarix (Vaccine), Vaccination, Sexually transmitted diseases -- Prevention, Papillomaviruses -- Prevention, Papillomavirus infections -- Prevention, Vaccines, Warts -- Prevention, Health, Diseases, Prevention
Abstract

If there were a vaccine available that could prevent an infectious disease, wouldn't you jump at the chance to be vaccinated? No, not for H IV infection--although this disease is [...]

Published
2007

33. Cervarix Vaccine

Subjects
Vaccines, Railroads, Email, Business, international, Cervarix (Vaccine)
Abstract

Tenders are invited for Cervarix vaccine. Tender Type: Limited Eligibility Criteria : - Major organization : NORTHERN RAILWAY Address : Ist Floor, Anne Buldg, Baroda House, New Delhi. Country :India [...]

Published
2019

34. Supply Of Cervarix Vaccine

Subjects
Vaccines, Railroads, Email, Business, international, Cervarix (Vaccine)
Abstract

Tenders are invited for Cervarix vaccine. Tender Type: Limited Eligibility Criteria : - Major organization : NORTHERN RAILWAY Address : Ist Floor, Anne Buldg, Baroda House, New Delhi. Country :India [...]

Published
2019

35. Cervical Cancer Treatment Market Size Worth USD 10.6 Billion by 2025: Grand View Research, Inc

Subjects
Cancer treatment, Vaccines -- Statistics, Cervical cancer, Papillomavirus infections, Cancer research, Generic drugs -- Statistics, Carboplatin -- Statistics, Squamous cell carcinoma, Angiogenesis inhibitors, Adenocarcinoma, Carcinoma, Cell differentiation, Anthracyclines, Business, News, opinion and commentary, Cervarix (Vaccine), Avastin (Medication)
Abstract

SAN FRANCISCO, January 16, 2019 /PRNewswire/ -- The global https://www.grandviewresearch.com/industry-analysis/cervical-cancer-treatment-market?utm_source=prnewswire.com&utm_medium=referral&utm_campaign=PRN_Jan16_Cervical_Cancer_Treatment_RD1&utm_content=Content size is expected to reach USD 10.6 billion by 2025, according to a new report by Grand View Research, Inc. [...]

Published
2019

36. Findings from University of Ferrara Provide New Insights into Vaccination (HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with ...)

Subjects
Cervical cancer -- Research, B cells, Vaccination, Papillomavirus, Infection, Characterization, Tumors, Public health, Editors, Diseases, Public health movements, Health, Cervarix (Vaccine)
Abstract

2020 FEB 5 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on Public Health - Vaccination. According to news reporting originating in [...]

Published
2020

37. New Findings from Zagazig University Yields New Data on Human Papillomavirus Vaccines (Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts)

Subjects
Antigens, Vaccines -- Research, Papillomavirus -- Research -- Care and treatment, Papillomavirus infections -- Research -- Care and treatment, Medical research, Infection, Public health, Editors, Health, Cervarix (Vaccine)
Abstract

2019 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Current study results on Immunization and Public Health - Human Papillomavirus Vaccines have been published. [...]

Published
2019

38. Study Data from Public Health England Provide New Insights into Human Papillomavirus Vaccines [Durability of the Neutralizing Antibody Response To Vaccine and Non-vaccine Hpv Types 7 Years Following Immunization With Either Cervarix ® or ...]

Subjects
Vaccines -- Research, Papillomavirus -- Research, Public health, Biopharmaceuticals -- Research, Genotypes, Editors, Health, Cervarix (Vaccine)
Abstract

2019 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Data detailed on Immunization and Public Health - Human Papillomavirus Vaccines have been presented. According [...]

Published
2019

39. Clinical: Clinical Review - Human papillomavirus

Subjects
Cancer -- Care and treatment, News, opinion and commentary, Cervarix (Vaccine)
Abstract

Contributed by Dr Anne Szarewski, clinical senior lecturer at the Wolfson Institute of Preventive Medicine, Queen Mary, University of London. Section 1: Epidemiology and aetiology Cervical cancer is a major [...]

Published
2012

40. GlaxoSmithKline partners with Alibaba for China HPV vaccine market grab

Subjects
Merck & Company Inc., Vaccines, Cervical cancer, Papillomavirus infections, Vaccination, Pharmaceutical industry, Business, international, Cervarix (Vaccine)
Abstract

GlaxoSmithKlines Cervarix is losing to Mercks Gardasil in the U.S. and Europe, but it hopes to win some scores from China. To do that, it has formed an alliance with [...]

Published
2017

42. Fewer HPV jabs provide equal protection

Subjects
Papillomavirus infections, Equality before the law, News, opinion and commentary, Cervarix (Vaccine)
Abstract

HPV vaccination with two doses of Cervarix, or even just one, may provide as much protection as three doses, a US study suggests. In the trial, researchers from the US [...]

Published
2011

43. Letters: The HPV immunisation debate needs clarifying

Subjects
Immunization, News, opinion and commentary, Cervarix (Vaccine)
Abstract

I have spent many years working in GUM and fully appreciate the problem of genital warts (GP, 1 April). I am also acutely aware of the lack of understanding among [...]

Published
2011

44. Letters: Cervarix could prevent cancer-related disease

Subjects
Vaccines, News, opinion and commentary, Cervarix (Vaccine)
Abstract

In respect of the choice of the two available vaccines to prevent HPV-associated disease, GUM physicians apparently prefer Gardasil (GP, 18 March). While this choice may preferentially impact on the [...]

Published
2011

45. Behind the Headlines: Should we protect girls from warts and cervical cancer?

Subjects
Vaccination -- Surveys, Papillomavirus infections -- Surveys, Cervical cancer -- Surveys, Cancer vaccines -- Surveys, Warts -- Surveys, News, opinion and commentary, Cervarix (Vaccine)
Abstract

Doctors have called for schoolgirls to be vaccinated against genital warts, according to news reports. A British Association for Sexual Health and HIV (BASHH) survey showed support for vaccination to [...]

Published
2011

46. Pharmacology Update: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix™)

Subjects
Vaccines, Antigens, Medical research, Medicine, Experimental, Papillomavirus infections, Pharmacology, Papillomaviruses, Health, Cervarix (Vaccine)
Abstract

Pharmacology Update Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix.sup.™) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD. Dr. Elliott is Chair, Formulary Committee, Northern [...]

Published
2010

47. Education: Journals Club - HPV vaccine

Subjects
Papillomavirus infections, Hydroxides, Vaccines, News, opinion and commentary, Cervarix (Vaccine)
Abstract

Curriculum statement 10.1 women's health and 11 sexual health Key trials - A phase III trial of the bivalent HPV vaccine has shown that efficacy against CIN2+ associated with HPV-16 [...]

Published
2010

48. Gardasil approved for use in males u Cervarix gets OK for use in females

Subjects
Merck & Company Inc., Warts -- Prevention, Papillomavirus infections -- Prevention, Cervical cancer -- Prevention, Cancer -- Care and treatment, Pharmaceutical industry, Cancer vaccines, Health, Cervarix (Vaccine)
Abstract

Gardasil approved for use in males -- Cervarix gets OK for use in females Both recommended for Vaccines for Children coverage Two new actions from the Food and Drug Administration [...]

Published
2009

49. Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix™)

Subjects
Vaccines, Antigens, Medical research, Medicine, Experimental, Papillomavirus infections, Papillomaviruses, Health, Cervarix (Vaccine)
Abstract

Pharmacology Update Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix.sup.™) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD. Dr. Elliott is Chair, Formulary Committee, Northern [...]

Published
2009

50. FDA approves cervical cancer vaccine

Subjects
Cervarix (Vaccine), Cervical cancer -- Prevention, Papillomavirus infections -- Prevention, Cancer -- Care and treatment, Drug approval, Cancer vaccines
Abstract

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's human papillomavirus bivalent (types 16 and 18) vaccine, recombinant (Cervarix) for the prevention of cervical precancers and cervical cancer associated [...]

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results